IL157600A0 - Promoters of the growth and/or differentiation of hematopoietic stem cells and/or hematopoietic progenitors - Google Patents

Promoters of the growth and/or differentiation of hematopoietic stem cells and/or hematopoietic progenitors

Info

Publication number
IL157600A0
IL157600A0 IL15760002A IL15760002A IL157600A0 IL 157600 A0 IL157600 A0 IL 157600A0 IL 15760002 A IL15760002 A IL 15760002A IL 15760002 A IL15760002 A IL 15760002A IL 157600 A0 IL157600 A0 IL 157600A0
Authority
IL
Israel
Prior art keywords
hematopoietic
differentiation
growth
stem cells
promoters
Prior art date
Application number
IL15760002A
Other languages
English (en)
Original Assignee
Daiichi Suntory Pharma Co Ltd
Daiichi Suntory Biomedical Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Suntory Pharma Co Ltd, Daiichi Suntory Biomedical Res filed Critical Daiichi Suntory Pharma Co Ltd
Publication of IL157600A0 publication Critical patent/IL157600A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/202—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL15760002A 2001-12-28 2002-12-27 Promoters of the growth and/or differentiation of hematopoietic stem cells and/or hematopoietic progenitors IL157600A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001400330 2001-12-28
PCT/JP2002/013862 WO2003057241A1 (fr) 2001-12-28 2002-12-27 Agents favorisant la proliferation et/ou la differenciation de cellules souches hematopoietiques et/ou de precurseurs hematopoietiques

Publications (1)

Publication Number Publication Date
IL157600A0 true IL157600A0 (en) 2004-03-28

Family

ID=19189604

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15760002A IL157600A0 (en) 2001-12-28 2002-12-27 Promoters of the growth and/or differentiation of hematopoietic stem cells and/or hematopoietic progenitors

Country Status (13)

Country Link
US (1) US7282201B2 (xx)
EP (1) EP1459758B1 (xx)
JP (1) JP4362066B2 (xx)
KR (1) KR100948346B1 (xx)
CN (1) CN1329078C (xx)
AT (1) ATE423567T1 (xx)
AU (1) AU2002359951B8 (xx)
BR (1) BR0207725A (xx)
CA (1) CA2439471A1 (xx)
DE (1) DE60231328D1 (xx)
ES (1) ES2321819T3 (xx)
IL (1) IL157600A0 (xx)
WO (1) WO2003057241A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767453B2 (en) * 2004-10-20 2010-08-03 Whitehead Institute For Biomedical Research Cultured hematopoietic stem cells and method for expansion and analysis thereof
JP5139271B2 (ja) * 2005-05-24 2013-02-06 ホワイトヘッド インスティチュート フォー バイオメディカル リサーチ 培養した造血幹細胞を拡大しかつ分析する方法
WO2007032566A1 (ja) * 2005-09-16 2007-03-22 Kenji Yoshida 造血幹細胞増殖剤
DE102006060247A1 (de) * 2006-09-15 2008-03-27 Ossacur Ag Differenzierung von Stammzellen
KR100980849B1 (ko) * 2007-04-25 2010-09-10 가톨릭대학교 산학협력단 인터루킨(ｉｌ)-10을 포함하는 조혈모세포의 자가 재생산을촉진하는 조성물
WO2008137641A2 (en) * 2007-05-04 2008-11-13 Whitehead Institute For Biomedical Research Ex vivo expansion of human hematopoietic stem cells
US8372389B2 (en) * 2007-11-28 2013-02-12 Hadasit Medical Research Services And Development Ltd. Methods for the treatment of radiation or chemotherapy-induced tissue damage
PE20100362A1 (es) 2008-10-30 2010-05-27 Irm Llc Derivados de purina que expanden las celulas madre hematopoyeticas
JP5519994B2 (ja) * 2009-10-19 2014-06-11 日揮株式会社 細胞培養装置及び細胞培養方法
US20130331326A1 (en) * 2011-02-21 2013-12-12 Duke University Method of inducing hematopoietic reconstruction
GB201210857D0 (en) 2012-06-19 2012-08-01 Cambridge Entpr Ltd Transcription factor mediated programming towards megakaryocytes
JP6584956B2 (ja) 2012-12-21 2019-10-02 アステラス インスティテュート フォー リジェネレイティブ メディシン 多能性幹細胞から血小板を生産するための方法およびその組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464817A (en) * 1990-04-11 1995-11-07 Brigham And Women's Hospital Method for reducing the viscosity of pathological mucoid airway contents in the respiratory tract comprising administering actin-binding compounds with or without DNASE I
JPH0550603A (ja) 1991-08-22 1993-03-02 Fujitsu Ltd 印字装置
JP4052680B2 (ja) 1993-03-18 2008-02-27 アスビオファーマ株式会社 新規ヒト白血病細胞株
US5856330A (en) 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
US6011051A (en) 1996-07-31 2000-01-04 Hoechst Aktiengesellschaft Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
WO2002053719A2 (en) * 2001-01-04 2002-07-11 Incyte Genomics, Inc. Cytoskeleton-associated proteins
GB0224014D0 (en) * 2002-10-15 2002-11-27 Oxford Glycosciences Uk Ltd A protein involved in therapy

Also Published As

Publication number Publication date
US7282201B2 (en) 2007-10-16
AU2002359951B8 (en) 2008-11-06
CN1329078C (zh) 2007-08-01
EP1459758A1 (en) 2004-09-22
KR20040075700A (ko) 2004-08-30
ES2321819T3 (es) 2009-06-12
AU2002359951B2 (en) 2008-06-19
CN1499980A (zh) 2004-05-26
ATE423567T1 (de) 2009-03-15
JP4362066B2 (ja) 2009-11-11
BR0207725A (pt) 2004-03-23
JPWO2003057241A1 (ja) 2005-05-12
EP1459758B1 (en) 2009-02-25
KR100948346B1 (ko) 2010-03-22
EP1459758A4 (en) 2006-02-22
CA2439471A1 (en) 2003-07-17
DE60231328D1 (de) 2009-04-09
US20040157326A1 (en) 2004-08-12
WO2003057241A1 (fr) 2003-07-17
AU2002359951A1 (en) 2003-07-24

Similar Documents

Publication Publication Date Title
WO2001085664A3 (en) Compounds and methods for regulating bacterial growth and pathogenesis
IL157600A0 (en) Promoters of the growth and/or differentiation of hematopoietic stem cells and/or hematopoietic progenitors
MX336807B (es) Composiciones y metodos para producir una composicion.
WO2006026570A8 (en) Use of stem cells to generate inner ear cells
ZA200307161B (en) Medical aerosol formulations
WO2002064096A3 (en) Methods of using pyrimidine-based antiviral agents
MXPA03007942A (es) Preparaciones de insulina exentas de zinc y con bajo contenido de zinc, que tienen una estabilidad mejorada.
WO2003011115A3 (en) Peptide-based multimeric targeted contrast agents
WO2005030169A8 (en) Methods for preparing oil bodies comprising active ingredients
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
HRP20080612T3 (en) Combination of tenofovir, ritonavir and tmc114
SG167670A1 (en) Aminocyclohexyl ether compounds and uses thereof
TW200507767A (en) Compositions containing coenzyme Q10
WO2003017924A3 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
MXPA04000874A (es) Composicion funguicida y uso de la composicion para controlar las enfermedades de las plantas.
WO2002007783A3 (en) Radiolabeled immunotoxins
TW200700085A (en) Endoparasiticidal compositions
SI1891961T1 (sl) Uporaba 5'-metiltioadenozina (MTA) za preprečevanje in/ali zdravljenje avtoimunske bolezni in/ali transplantacijske zavrnitve
WO2003087353A3 (en) Purified polypeptides involved in membrane biogenesis
MY140724A (en) Novel arylethene-sulfonamides
WO2004034961A3 (en) Antimicrobial agents and uses thereof
AU2003251729A1 (en) Use of antibodies against flt-1 for the treatment of osteoporosis
WO2002102324A3 (en) Anti-arthropod vector vaccines methods of selecting and uses thereof
SG185137A1 (en) Biologically active peptides
WO2001077365A3 (en) Antimicrobial methods and materials

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees